¿Cómo se compara el ratio PE de EBO con empresas similares?

EBO es un buen valor basado en su ratio Price-To-Earnings (24.1x) comparado con la media de empresas similares (48.8x).

¿Cómo se compara el ratio PE de EBO con el de otras empresas de la industria Global Healthcare ?

EBO es cara en función de su ratio Price-To-Earnings (24.1x) en comparación con la media de la industria NZ Healthcare (12x).

¿Cuál es el ratio PE de EBO comparado con su ratio PE justo? Este es el ratio PE esperado teniendo en cuenta las estimaciones de crecimiento de ingresos de la empresa, los márgenes de beneficios y otros factores de riesgo.

EBO es cara según su ratio Price-To-Earnings (24.1x) comparado con el ratio justo estimado Price-To-Earnings (14.6x).

¿Cuál es el precio justo de EBO si consideramos sus flujos de caja futuros? Para esta estimación utilizamos un modelo de flujo de caja descontado.

EBO (NZ$37.22) cotiza por debajo de nuestra estimación de [[valor justo]] (NZ$47.06)

¿Cuál es la estimación de los analistas a 12 meses y, existe una confianza estadística en el precio objetivo de consenso?

El precio objetivo es inferior al 20% superior al precio actual de la acción.

EBOS Group (NZSE:EBO) - Cotización, noticias y análisis

Resumen de acción EBO

EBOS Group Limited se dedica a la comercialización, venta al por mayor y distribución de productos sanitarios, médicos, farmacéuticos y para el cuidado de los animales en Australia, el Sudeste Asiático y Nueva Zelanda. Saber más

Análisis fundamental de EBO
Puntuación del snowflake
Valoración	3/6
Crecimiento futuro	1/6
Rendimiento pasado	2/6
Salud financiera	3/6
Dividendos	4/6

Recompensas

Cotiza un 20.9% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 6.88%

Los beneficios han crecido un 13.5% al año en los últimos 5 años

Análisis de riesgos

Tiene un alto nivel de endeudamiento

El dividendo de 3.38% no está bien cubierto por los flujos de efectivo libres

Competidores de EBOS Group Limited

Summerset Group Holdings

NZSE:SUM

NZ$3.1b

Arvida Group

NZSE:ARV

NZ$1.2b

Fisher & Paykel Healthcare

NZSE:FPH

NZ$21.7b

Jointown Pharmaceutical Group

SHSE:600998

CN¥26.9b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de EBOS Group
Precios históricos de las acciones
Precio actual de la acción	NZ$37.22
Máximo en las últimas 52 semanas	NZ$37.99
Mínimo de 52 semanas	NZ$31.02
Beta	0.26
1Cambio en 1 mes	1.86%
Variación en 3 meses	3.39%
Cambio de 1 año	5.11%
3Variación en 3 años	3.45%
Variación en 5 años	63.25%
Variación desde la OPV	1,540.12%

Noticias y actualizaciones recientes

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

Nov 11

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Oct 16

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Oct 11

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29

Recent updates

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

Nov 11

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Oct 16

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Oct 11

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Sep 29

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Sep 15

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

Feb 23

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

Jan 23

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Dec 18

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Nov 02

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

Oct 17

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

Oct 02

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Aug 02

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Jun 26

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

May 02

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Apr 14

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

Mar 14

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 26

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jan 06

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Nov 28

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

Oct 21

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

Oct 05

Does EBOS Group (NZSE:EBO) Have A Healthy Balance Sheet?

Sep 13

EBOS Group (NZSE:EBO) Will Pay A Larger Dividend Than Last Year At A$0.5116

Aug 26

Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

Jun 24

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

May 10

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

Mar 17

We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

Feb 26

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

Feb 18

EBOS Group Limited's (NZSE:EBO) Intrinsic Value Is Potentially 41% Above Its Share Price

Jan 22

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Dec 26

EBOS Group (NZSE:EBO) Has Some Way To Go To Become A Multi-Bagger

Oct 31

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 23% Undervalued

Oct 18

Is EBOS Group (NZSE:EBO) A Risky Investment?

Sep 19

Here's Why I Think EBOS Group (NZSE:EBO) Might Deserve Your Attention Today

Aug 05

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

Jul 13

EBOS Group's (NZSE:EBO) Returns Have Hit A Wall

Jun 09

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

May 01

Here's Why EBOS Group (NZSE:EBO) Can Manage Its Debt Responsibly

Apr 08

A Look At The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Mar 27

Is EBOS Group Limited's (NZSE:EBO) Recent Performance Tethered To Its Attractive Financial Prospects?

Mar 15

Is EBOS Group Limited (NZSE:EBO) A Smart Pick For Income Investors?

Mar 03

Rentabilidad de los accionistas

	EBO	NZ Healthcare	Mercado NZ
7D	0.05%	1.0%	0.1%
1Y	5.1%	9.4%	9.6%

Rentabilidad vs. Industria: Los resultados de EBO fueron inferiores a los de la industria NZ Healthcare, que obtuvo un rendimiento del 9.4% el año pasado.

Rentabilidad vs. Mercado: EBO obtuvo unos resultados inferiores a los del mercado NZ, que fueron del 9.6% el año pasado.

Volatilidad de los precios

Is EBO's price volatile compared to industry and market?
EBO volatility
EBO Average Weekly Movement	3.4%
Healthcare Industry Average Movement	4.2%
Market Average Movement	4.5%
10% most volatile stocks in NZ Market	9.3%
10% least volatile stocks in NZ Market	3.0%

Precio estable de las acciones: EBO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de EBO (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1922	4,557	John Cullity	www.ebosgroup.com

EBOS Group Limited se dedica a la comercialización, venta al por mayor y distribución de productos sanitarios, médicos, farmacéuticos y para el cuidado de animales en Australia, el Sudeste Asiático y Nueva Zelanda. Opera a través de los segmentos Healthcare y Animal Care. La empresa ofrece servicios de logística sanitaria; soluciones de gestión de medicamentos; software de gestión de farmacias; servicios de fidelización, genéricos, cumplimiento, inteligencia empresarial y software para tiendas; y comunicaciones, programas y servicios de consultoría en materia de salud.

Resumen de fundamentos de EBOS Group Limited

¿Cómo se comparan los beneficios e ingresos de EBOS Group con su capitalización de mercado?
Estadísticas fundamentales de EBO
Capitalización bursátil	NZ$7.21b
Beneficios(TTM)	NZ$301.11m
Ingresos (TTM)	NZ$14.63b

24.1x

Ratio precio-beneficio (PE)

0.5x

Ratio precio-ventas (PS)

¿Está EBO sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de EBO
Ingresos	AU$13.19b
Coste de los ingresos	AU$11.56b
Beneficio bruto	AU$1.63b
Otros gastos	AU$1.36b
Beneficios	AU$271.55m

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	1.39
Margen bruto	12.38%
Margen de beneficio neto	2.06%
Ratio deuda/patrimonio	51.1%

¿Cómo se ha desempeñado EBO a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

3.4%

Rentabilidad actual por dividendo

78%

Ratio de pagos

Resumen de acción EBO

Recompensas

Análisis de riesgos

Competidores de EBOS Group Limited

NZSE:SUM

NZ$3.1b

NZSE:ARV

NZ$1.2b

NZSE:FPH

NZ$21.7b

SHSE:600998

CN¥26.9b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Now 21% undervalued

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

EBOS Group Limited Announces the Retirement of Peter Williams as Director

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Recent updates

Now 21% undervalued

The Returns At EBOS Group (NZSE:EBO) Aren't Growing

EBOS Group Limited Announces the Retirement of Peter Williams as Director

Shareholders May Be More Conservative With EBOS Group Limited's (NZSE:EBO) CEO Compensation For Now

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

Do EBOS Group's (NZSE:EBO) Earnings Warrant Your Attention?

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 22% Undervalued

Final dividend of NZ$0.64 announced

EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Earnings Not Telling The Story For EBOS Group Limited (NZSE:EBO)

Are Investors Undervaluing EBOS Group Limited (NZSE:EBO) By 29%?

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

EBOS Group Limited Announces Chief Financial Officer Changes

EBOS Group (NZSE:EBO) Seems To Use Debt Quite Sensibly

Some Confidence Is Lacking In EBOS Group Limited's (NZSE:EBO) P/E

Insider recently sold NZ$5.3m worth of stock

EBOS Group (NZSE:EBO) Will Pay A Dividend Of A$0.5951

First half dividend of NZ$0.60 announced

EBOS Group Limited (NZSE:EBO) Just Released Its Half-Year Earnings: Here's What Analysts Think

First half 2024 earnings released: EPS: AU$0.71 (vs AU$0.70 in 1H 2023)

EBOS Group Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

Now 21% undervalued

Returns At EBOS Group (NZSE:EBO) Appear To Be Weighed Down

EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024

Now 21% undervalued

EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million.

EBOS Group Limited's (NZSE:EBO) Business Is Trailing The Market But Its Shares Aren't

Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk

Now 22% undervalued after recent price drop

EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit

EBOS Not to Proceed with Acquisition in Animal Care Segment

EBOS Not to Proceed with Acquisition in Animal Care Segment

Now 20% undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 20% Undervalued

Here's What To Make Of EBOS Group's (NZSE:EBO) Decelerating Rates Of Return

EBOS Group (NZSE:EBO) Has A Pretty Healthy Balance Sheet

EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023

Now 20% undervalued

Upcoming dividend of NZ$0.60 per share at 3.0% yield

EBOS Group's (NZSE:EBO) Upcoming Dividend Will Be Larger Than Last Year's

Ebos Group Limited Announces Dividend, Payable on 29 September 2023

Full year 2023 earnings: EPS misses analyst expectations

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Is Reinvesting At Lower Rates Of Return

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued after recent price drop

Estimating The Intrinsic Value Of EBOS Group Limited (NZSE:EBO)

Is EBOS Group (NZSE:EBO) Using Too Much Debt?

EBOS Group (NZSE:EBO) Could Be Struggling To Allocate Capital

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

First half 2023 earnings released: EPS: AU$0.70 (vs AU$0.61 in 1H 2022)

EBOS Group Limited to Report Q2, 2023 Results on Feb 22, 2023

A Look At The Fair Value Of EBOS Group Limited (NZSE:EBO)

EBOS Group (NZSE:EBO) Might Be Having Difficulty Using Its Capital Effectively

Here's Why EBOS Group Limited's (NZSE:EBO) CEO Compensation Is The Least Of Shareholders' Concerns

EBOS Group Limited (NZSE:EBO) Shares Could Be 37% Below Their Intrinsic Value Estimate

EBOS Group Limited Announces the Appointment of Mark Bloom as an Independent Director, Effective 16 September 2022